New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
Items 201–300 of 1,000
Ye, N., Chen, C.-H., Chen, T., Song, Z., He, J., Huan, X., Song, S.-S., Liu, Q., Chen, Y., Ding, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301825t · Cited by 97
Park, H. J., Bae, J. S., Kim, K. M., Moon, Y. J., Park, S., Ha, S. H., Hussein, U. K., Zhang, Z., Park, H. S., Park, B., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0772-9 · Cited by 89
Mechanism of PARP inhibitor resistance and potential overcoming strategies
Fu, X., Li, P., Zhou, Q., He, R., Wang, G., Zhu, S., Bagheri, A., Kupfer, G. M., Pei, H., & Li, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.014 · Cited by 94
Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases
Vittal, V., Stewart, M. D., Brzovic, P. S., & Klevit, R. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.675165 · Cited by 88
“Protein poly(ADP-ribosyl)ation (PARylation) is a post-translational modification linked to DNA repair, Wnt signaling, and transcription (73).”
BackgroundCao, C.-G., Yang, J., Chen, Y. X., Zhou, P., Wang, Y., Du, W., Zhao, L., & Chen, Y. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00821 · Cited by 91
Resveratrol and cardiovascular health – Promising therapeutic or hopeless illusion?
Tang, P. C., Ng, Y.-F., Ho, S., Gyda, M., & Chan, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.08.001 · Cited by 95
Liu, L., Li, J., Ke, Y., Zeng, X., Gao, J., Ba, X., & Wang, R. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04109-w · Cited by 93
Karlberg, T., Klepsch, M. M., Thorsell, A. G., Andersson, C. D., Linusson, A., & Schuler, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.630160 · Cited by 86
“Of the 17 human family members, at least PARP1/ARTD1 and the closely related PARP2/ARTD2, as well as the tankyrases (ARTD5 and ARTD6), have documented poly(ADP-ribose) polymerase activity (18, 19).”
BackgroundADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function
Weixler, L., Schäringer, K., Momoh, J., Lüscher, B., Feijs, K. L. H., & Žaja, R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab136 · Cited by 89
“Furthermore, it is involved in homologous recombination and other cellular processes like the modulation of the chromatin structure and gene expression (23,37,38).”
BackgroundHost-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
Krug, S., Parveen, S., & Bishai, W. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660916 · Cited by 85
New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair
Jelinic, P., & Levine, D. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0906-t · Cited by 93
Gill, S. J., Travers, J., Pshenichnaya, I., Kogera, F. A., Barthorpe, S., Mironenko, T., Richardson, L., Benes, C. H., Stratton, M. R., McDermott, U., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140988 · Cited by 83
“SSBs drive PARP1/2 (hereafter referred to as PARP) binding to DNA, catalysing a series of PARylation events that promote DNA repair processes [8].”
BackgroundEngineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins
Nowak, K., Rosenthal, F., Karlberg, T., Bütepage, M., Thorsell, A.-G., Dreier, B., Grossmann, J., Sobek, J., Imhof, R., Lüscher, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18981-w · Cited by 80
Parsons, L. P., Challa, S., Gibson, B. A., Nandu, T. S., Stokes, M. S., Huang, D., Lea, J. S., & Kraus, W. L. (2021) · eLife · doi:10.7554/elife.60481 · Cited by 88
Self-citationPARP inhibitors: polypharmacology versus selective inhibition
Ekblad, T., Camaioni, E., Schuler, H., & Macchiarulo, A. (2013) · FEBS Journal · doi:10.1111/febs.12298 · Cited by 84
Poly-ADP ribosylation in DNA damage response and cancer therapy
Hou, W., Chen, S.-H., & Yu, X. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.09.004 · Cited by 87
The Bump-and-Hole Tactic: Expanding the Scope of Chemical Genetics
Islam, K. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.07.001 · Cited by 85
Wnts and the hallmarks of cancer
Zhong, Z., Yu, J., Virshup, D. M., & Madan, B. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09887-6 · Cited by 85
Liu, T., Song, S., Wang, X., & Hao, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112954 · Cited by 84
The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62
Linares, J. F., Cid-Diaz, T., Duran, A., Osrodek, M., Martinez-Ordoñez, A., Reina-Campos, M., Kuo, H.-H., Elemento, O., Martin, M. L., Cordes, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110792 · Cited by 76
“PARP-1 is the major isoform of the PARP enzyme family and, like the other PARPs, its PARylation activity impacts multiple biological processes with a main dual function in DDR and transcriptional regulation (Feng et al., 2015; Gibson and Kraus, 2012).”
ENPP 1 processes protein ADP ‐ribosylation in vitro
Palazzo, L., Daniels, C. M., Nettleship, J. E., Rahman, N., McPherson, R. L., Ong, S., Kato, K., Nureki, O., Leung, A. K. L., & Ahel, I. (2016) · FEBS Journal · doi:10.1111/febs.13811 · Cited by 81
An Overview of Pathways of Regulated Necrosis in Acute Kidney Injury
Kers, J., Leemans, J. C., & Linkermann, A. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.03.002 · Cited by 80
“Upon release from the mitochondria, AIFM-1 shuttles to the nucleus to mediate DNA fragmentation via the formation of a complex with histone 2AX and cyclophilin A.”
BackgroundInfluentialPoly(ADP-ribose) drives condensation of FUS via a transient interaction
Rhine, K., Dasovich, M., Yoniles, J., Badiee, M., Skanchy, S., Ganser, L. R., Ge, Y., Fare, C. M., Shorter, J., Leung, A. K. L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.018 · Cited by 90
The Chromatin Response to Double-Strand DNA Breaks and Their Repair
Aleksandrov, R., Hristova, R. H., Stoynov, S., & Gospodinov, A. G. (2020) · Cells · doi:10.3390/cells9081853 · Cited by 90
“These PAR chains serve as binding sites for the recruitment of downstream DNA repair factors, which actually repair the lesion [79,286,288,289].”
BackgroundPoly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer
Kwan, T. T., Bock, F. J., & Chang, P. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.002 · Cited by 85
Expanding functions of intracellular resident mono‐ADP‐ribosylation in cell physiology
Feijs, K. L. H., Verheugd, P., & Lüscher, B. (2013) · The FEBS Journal · doi:10.1111/febs.12315 · Cited by 73
New directions in poly(ADP‐ribose) polymerase biology
Bock, F. J., & Chang, P. (2016) · FEBS Journal · doi:10.1111/febs.13737 · Cited by 80
Identifying Poly(ADP-ribose)-Binding Proteins with Photoaffinity-Based Proteomics
Dasovich, M., Beckett, M. Q., Bailey, S., Ong, S., Greenberg, M. M., & Leung, A. K. L. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c12246 · Cited by 80
Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer
Michels, J., Vitale, I., Senovilla, L., Enot, D. P., Garcia, P., Lissa, D., Olaussen, K. A., Brenner, C., Soria, J.-C., Castedo, M., et al. (2013) · Cell Cycle · doi:10.4161/cc.24034 · Cited by 73
Ciccarone, F., Klinger, F. G., Catizone, A., Calabrese, R., Zampieri, M., Bacalini, M. G., De Felici, M., & Caiafa, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046927 · Cited by 74
“Moreover, non-covalent interaction with protein-bound or free ADP-ribose polymers (PARs) can also occur [23,26,27].”
BackgroundMichel, L. S., Dyroff, S. L., Brooks, F. J., Spayd, K. J., Lim, S., Engle, J. T., Phillips, S. E., Tan, B. R., Wang‐Gillam, A., Bognar, C., et al. (2016) · Radiology · doi:10.1148/radiol.2016161929 · Cited by 78
The fork and the kinase: A DNA replication tale from a CHK1 perspective
González Besteiro, M. A., & Gottifredi, V. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.10.003 · Cited by 69
“In response to DNA damage, PARP1 catalyzes PARylation of itself and other substrates, thereby controlling diverse aspects of the DNA damage response [61].”
BackgroundMolecular basis for DarT ADP-ribosylation of a DNA base
Schuller, M., Butler, R. E., Ariza, A., Tromans‐Coia, C., Jankevicius, G., Claridge, T. D. W., Kendall, S. L., Goh, S., Stewart, G. R., & Ahel, I. (2021) · Nature · doi:10.1038/s41586-021-03825-4 · Cited by 82
In vivo imaging of specific drug–target binding at subcellular resolution
Dubach, J. M., Vinegoni, C., Mazitschek, R., Fumene Feruglio, P., Cameron, L. A., & Weissleder, R. (2014) · Nature Communications · doi:10.1038/ncomms4946 · Cited by 76
Fluorescence anisotropy imaging in drug discovery
Vinegoni, C., Feruglio, P. F., Gryczyński, I., Mazitschek, R., & Weissleder, R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.019 · Cited by 81
“Poly(ADP-ribose)polymerase (PARP) comprises a family of enzymes playing a fundamental role for DNA repair [418-420] and is upregulated in a large number of types of cancer [421-425].”
PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress
Schleicher, E. M., Galvan, A. M., Kawasawa, Y. I., Moldovan, G., & Nicolae, C. M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky658 · Cited by 83
“The poly-ADP-ribose polymerase (PARP) family of ADP-ribosyltransferases encompasses 17 enzymes with a PARP catalytic domain in their C-termini (1,2).”
BackgroundProtein Poly(ADP-ribosyl)ation Regulates Arabidopsis Immune Gene Expression and Defense Responses
Feng, B., Liu, C., de Oliveira, M. V. V., Intorne, A. C., Li, B., Babilonia, K., Filho, G. A. D. S., Shan, L., & He, P. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004936 · Cited by 93
“In vertebrate, ADP-ribosyl hydrolase 3 (ARH3), a structurally distinct enzyme from PARG, could also degrade PAR polymers associated with the mitochondrial matrix [26].”
BackgroundInfluentialChen, Y., Zhang, H., Xu, Z., Tang, H., Geng, A., Cai, B., Su, T., Shi, J., Jiang, C., Tian, X., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz592 · Cited by 87
HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase
Rudolph, J., Roberts, G., Muthurajan, U. M., & Luger, K. (2021) · eLife · doi:10.7554/elife.65773 · Cited by 79
Zhou, Y., Lih, T. M., Pan, J., Höti, N., Dong, M., Cao, L., Hu, Y., Cho, K.-C., Chen, S., Eguez, R. V., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01013-x · Cited by 86
“PARP1 is a nuclear enzyme, and plays a significant role in the maintenance of genome integrity, DNA repair and cell death [50, 51].”
BackgroundSerra, V., Wang, A. T., Castroviejo‐Bermejo, M., Polanska, U. M., Palafox, M., Herencia-Ropero, A., Jones, G. N., Lai, Z., Armenia, J., Michopoulos, F., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0568 · Cited by 77
Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer
Hyeraci, M., Papanikolaou, E. S., Grimaldi, M., Ricci, F., Pallotta, S., Monetta, R., Minafò, Y. A., Lella, G. D., Galdo, G., ABENI, D. D., et al. (2023) · Biomolecules · doi:10.3390/biom13071067 · Cited by 85
“Importantly, PARP is a nuclear enzyme that is activated in response to DNA damage to promote and coordinate DNA repair processes [38].”
BackgroundTailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations
Madariaga, A., Lheureux, S., & Oza, A. M. (2019) · Cancers · doi:10.3390/cancers11030416 · Cited by 82
“They function in cellular signaling pathways, including DNA repair, transcriptional regulation, RNA interference, mitochondrial function, formation of subnuclear bodies and in cell division [116].”
BackgroundLuo, X., Nie, J., Wang, S., Chen, Z., Chen, W., Li, D., Hu, H., & Li, B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661611 · Cited by 73
“Reduced Poly(ADP-ribosyl)ation of FOXP3 Results in FOXP3 Stabilization in Treg Cells—3-AB is a widely used PARP-1 inhibitor, and AG14361 is a potent PARP-1-specific inhibitor, and they have been shown to effectively block PARP-1 catalytic activity (24).”
BackgroundDevelopment of Synthetic Lethality Anticancer Therapeutics
Fang, B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500415t · Cited by 81
PARP, transcription and chromatin modeling
Marjanović, M. P., Crawford, K., & Ahel, I. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.09.014 · Cited by 78
“The involvement of protein DP-ribosylation in main cellular processes such as DNA damage esponse (DDR), transcription, chromatin architecture and plasicity, differentiation and metabolism has been well investigated nd documented (recently reviewed in [9,12,25,41,56,71]).”
BackgroundChand, S. N., Zarei, M., Schiewer, M. J., Kamath, A. R., Romeo, C., Lal, S., Cozzitorto, J. A., Nevler, A., Scolaro, L. M., Londin, E. R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2704 · Cited by 73
“We performed a focused screen of DNA repair enzymes critical for regulating PAR turnover to identify potential mRNA targets (34).”
Gao, X., Wang, J., Li, M., Wang, J., Lv, J., Zhang, L., Sun, C., Ji, J., Yang, W., Zhao, Z., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14560 · Cited by 75
Fischer, J. M. F., Popp, O., Gebhard, D., Veith, S., Fischbach, A., Beneke, S., Leitenstorfer, A., Bergemann, J., Scheffner, M., Ferrando‐May, E., et al. (2014) · The FEBS Journal · doi:10.1111/febs.12885 · Cited by 72
Streppel, M. M., Pai, S., Campbell, N. R., Hu, C., Yabuuchi, S., Canto, M. I., Wang, J. S., Montgomery, E. A., & Maitra, A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0601 · Cited by 70
“results in automodification, self-activation, and the addition of poly (ADP-ribose) polymers to itself and surrounding histones (28, 43).”
BackgroundPARP14 inhibits microglial activation via LPAR5 to promote post-stroke functional recovery
Tang, Y., Liu, J., Wang, Y., Yang, L., Han, B., Zhang, Y., Bai, Y., Shen, L., Li, M., Jiang, T., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1847799 · Cited by 75
“ADP-ribosylation is a universal post-translational modification and controls multiple cellular processes such as DNA repair, chromatin plasticity, transcriptional regulation, and cell differentiation [11,16].”
BackgroundPARPs in genome stability and signal transduction: implications for cancer therapy
Palazzo, L., & Ahel, I. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180418 · Cited by 79
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
Pu, H., Horbinski, C., Hensley, P. J., Matuszak, E. A., Atkinson, T. H., & Kyprianou, N. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu183 · Cited by 71
“Under low levels of DNA damage, PARP-1 acts as a survival factor specifically involved in DNA repair while, in the presence of extensive DNA damage, PARP-1 promotes apoptosis (2).”
BackgroundAbu‐Zhayia, E. R., Awwad, S. W., Ben‐Oz, B. M., Khoury-Haddad, H., & Ayoub, N. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx050 · Cited by 71
Barbour, H., Nkwe, N. S., Estavoyer, B., Messmer, C., Gushul-Leclaire, M., Villot, R., Uriarte, M., Boulay, K., Hlayhel, S., Farhat, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106276 · Cited by 79
“Having NAD-dependent catalytic activity, PARPs add one or multiple negatively charged ADP-ribose molecules (PAR) on target proteins, allowing the regulation of their functions.(110) The majority of studies investigating the biological function(s) of poly-ADP-ribosylation (PARylation) were conducted in the context of D…”
BackgroundRoles of Poly(ADP-Ribose) Glycohydrolase in DNA Damage and Apoptosis
Feng, X., & Koh, D. W. (2013) · International review of cytology · doi:10.1016/b978-0-12-407696-9.00005-1 · Cited by 72
Nicolae, C. M., Aho, E. R., Choe, K. N., Constantin, D., Hu, H.-J., Lee, D., Myung, K., & Moldovan, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv147 · Cited by 79
“Poly-ADP-ribosylation catalyzed by PARP1 regulates base excision repair and the signaling at double strand breaks (32).”
BackgroundSuccesses and Challenges of PARP Inhibitors in Cancer Therapy
Ricks, T. K., Chiu, H.-J., Ison, G., Kim, G., McKee, A. E., Kluetz, P. G., & Pazdur, R. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00222 · Cited by 72
“Poly (ADP-ribose) polymerases (PARPs) are a family of enzymes involved in cellular homeostasis, including DNA transcription, cell-cycle regulation, and DNA repair (1, 2).”
BackgroundFunctional Interplay between Histone H2B ADP-Ribosylation and Phosphorylation Controls Adipogenesis
Huang, D., Camacho, C. V., Setlem, R., Ryu, K. W., Parameswaran, B., Gupta, R. K., & Kraus, W. L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.08.002 · Cited by 76
“ADP-ribosylation (ADPRylation) is an NAD+-dependent post-translational modification of proteins, primarily on glutamate (Glu), aspartate (Asp), and serine (Ser) residues, which is mediated by the poly(ADP-ribosyl) transferase (PARP) family of enzymes (Gibson and Kraus, 2012; Ryu et al., 2015).”
BackgroundSelf-citationADPriboDB: The database of ADP-ribosylated proteins
Vivelo, C. A., Wat, R., Agrawal, C., Tee, H. Y., & Leung, A. K. L. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw706 · Cited by 66
“ADP-ribosylation has numerous and diverse effects on protein functions and cellular pathways, including DNA damage, transcription, chromatin organization, stress responses, circadian rhythms, cell cycle regulation and RNA metabolism (2,20–24).”
BackgroundIqbal, M. B., Johns, M. S., Cao, J., Liu, Y., Yu, S.-C., Hyde, G. D., Laffan, M., Marchese, F. P., Cho, S. H., Clark, A. R., et al. (2014) · Blood · doi:10.1182/blood-2014-07-588046 · Cited by 70
“There are at least 17 intracellular proteins containing a poly (adenosine 59-diphosphate [ADP]-ribose) polymerase (PARP) domain.(22) PARP-1, the canonical PARP protein, has been extensively studied and it is of central importance to DNA repair and transcriptional regulation.”
BackgroundNile, D. L., Rae, C. J., Hyndman, I., Gaze, M. N., & Mairs, R. J. (2016) · BMC Cancer · doi:10.1186/s12885-016-2656-8 · Cited by 72
“Innovative PARP-1 inhibitors, such as olaparib and rucaparib, have greater specificity, enhanced target affinity, and have now progressed to clinical evaluation [12, 16, 29].”
A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer
Zhen, Y., Zhang, Y., & Yu, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.106 · Cited by 75
“Indeed, a number of PAR-binding motifs (PBMs) have been identified, including WWE, PBZ, BRCT, macrodomain and OB-fold (Gibson and Kraus, 2012, Liu et al., 2017).”
BackgroundShriwas, O., Mohapatra, P., Mohanty, S., & Dash, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612337 · Cited by 70
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
Khalili‐Tanha, G., & Moghbeli, M. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00282-9 · Cited by 69
“It is also involved in cell cycle and transcriptional regulations [70].”
BackgroundKarlberg, T., Langelier, M.-F., Pascal, J. M., & Schuler, H. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.02.002 · Cited by 72
Poly(ADP-Ribose) Mediates the BRCA2-Dependent Early DNA Damage Response
Zhang, F., Shi, J., Bian, C., & Yu, X. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.040 · Cited by 72
“Anti-PARP1, anti-PARP2 and anti-BRCA2antibodies were purchased from Millipore.”
BackgroundInfluentialZhang, F., Chen, Y., Mo, L., & Yu, X. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318367111 · Cited by 71
PARP-1 Regulates Resistance of Pancreatic Cancer to TRAIL Therapy
Yuan, K., Sun, Y., Zhou, T., McDonald, J. M., & Chen, Y. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0516 · Cited by 67
“The PARPs are key to repairing damaged DNA by modifying proteins associated with DNA repair (29).”
BackgroundInfluentialKutuzov, M. M., Belousova, E. A., Kurgina, T. A., Ukraintsev, A. A., Васильева, И. А., Khodyreva, S. N., & Lavrik, O. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-84351-1 · Cited by 71
Post-Transcriptional Regulation by Poly(ADP-ribosyl)ation of the RNA-Binding Proteins
Ji, Y., & Tulin, A. V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816168 · Cited by 75
“recruits the DNA repair proteins to the DNA-damaged sites [12,66].”
Role of SIRT1 in autoimmune demyelination and neurodegeneration
Martin, A., Tegla, C., Cudrici, C. D., Kruszewski, A. M., Azimzadeh, P. N., Boodhoo, D., Mekala, A. P., Rus, V., & Rus, H. (2014) · Immunologic Research · doi:10.1007/s12026-014-8557-5 · Cited by 72
“Moreover, SIRT 3, 4, 5, and 6 have been reported to have other functions, including ADP-ribosyltransferase activity [39, 40] (Table 2).”
BackgroundThe PIN domain of EXO1 recognizes poly(ADP-ribose) in DNA damage response
Zhang, F., Shi, J., Chen, S.-H., Bian, C., & Yu, X. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv939 · Cited by 70
Silva, A. P. G., Ryan, D. P., Galanty, Y., Low, J. K. K., Vandevenne, M., Jackson, S. P., & Mackay, J. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.683227 · Cited by 63
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Morgan, R. D., Clamp, A. R., Evans, D. G., Edmondson, R. J., & Jayson, G. C. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3532-9 · Cited by 69
“The most abundant and well-characterised members are PARP-1 and PARP-2, which have a role in DNA damage detection and repair [27].”
BackgroundThe expanding role of PARP s in the establishment and maintenance of heterochromatin
Dantzer, F., & Santoro, R. (2013) · FEBS Journal · doi:10.1111/febs.12368 · Cited by 72
Danhauser, K., Alhaddad, B., Makowski, C. C., Piekutowska‐Abramczuk, D., Syrbe, S., Gomez‐Ospina, N., Manning, M. A., Kostera‐Pruszczyk, A., Krahn-Peper, C., Berutti, R., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.005 · Cited by 75
“ADPRHL2 is thought to function in the pathway of ADPribosylation, which is a reversible posttranslational modification used to regulate key cellular processes such as transcription, DNA repair, translation, and apoptosis.(4) In humans, severalADP-ribose transferases transferADP-ribose from nicotinamide adenine dinucle…”
BackgroundResistance to PARP Inhibitors: Lessons from Preclinical Models of BRCA-Associated Cancer
Gogola, E., Rottenberg, S., & Jonkers, J. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050232 · Cited by 71
“PARPs transfer negatively charged ADP-ribose groups from donor NAD+ onto target proteins in a process termed poly(ADP-ribose)ylation (PARylation) (Gibson & Kraus 2012).”
BackgroundNADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
Bian, C., Zhang, C., Luo, T., Vyas, A., Chen, S.-H., Liu, C., Kassab, M. A., Yang, Y., Kong, M., & Yu, X. (2019) · Nature Communications · doi:10.1038/s41467-019-08530-5 · Cited by 71
The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis
Lu, L., An, T., Zhang, Q., Wei, Y., & Wei, X. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa055 · Cited by 72
“PARP1 belongs to the family of PARP proteins, which transfer ADP-ribose groups from NADþ to multiple substrates and then control cellular processes (Gibson and Kraus, 2012).”
BackgroundChalla, S., Stokes, M. S., & Kraus, W. L. (2021) · Cells · doi:10.3390/cells10020313 · Cited by 66
“The MARTs are also capable of modifying a variety of amino acid residues, such as Ser, Asp, Glu, and Cys, thus diversifying the repertoire of MARylation targets [3,22].”
BackgroundSelf-citationStructural insight into the interaction of ADP‐ribose with the PARP WWE domains
He, F., Tsuda, K., Takahashi, M., Kuwasako, K., Terada, T., Shirouzu, M., Watanabe, S., Kigawa, T., Kobayashi, N., Güntert, P., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.009 · Cited by 65
Ding, X., Zeng, T., Wei, Z., Yu, Z.-Z., Huang, W., Yi, H., Lu, S.-S., Feng, J., Feng, X., Wu, D., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0896 · Cited by 67
Schweikl, H., Petzel, C., Bolay, C., Hiller, K., Buchalla, W., & Krifka, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.044 · Cited by 64
“Yet, the function of the activation of uncleaved PARP-1 byHEMA in the cytosolic fraction as shown here is currently unclear, although physiological functions other than DNA nicksensing have been suggested [54,55].”
Chaudhuri, A. R., Ahuja, A. K., Herrador, R., & Lopes, M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01077-14 · Cited by 67
“teins of the poly(ADP) ribose polymerase family (PARP), mostly PARP1 (1).”
BackgroundInfluentialInhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium
Cooper, K. L., Dashner, E. J., Tsosie, R. L., Cho, Y. M., Lewis, J. L., & Hudson, L. G. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.11.017 · Cited by 64
“PARP-1 binds to DNA through two C3H1 zinc finger motifs and binding to damaged DNA activates PARP-1 enzymatic activity (Gibson and Kraus, 2012; Dantzer and Santoro, 2013; Langelier and Pascal, 2013).”
BackgroundGermline PARP4 mutations in patients with primary thyroid and breast cancers
Ikeda, Y., Kiyotani, K., Yew, P. Y., Kato, T., Tamura, K., Yap, K. L., Nielsen, S. M., Mester, J. L., Eng, C., Nakamura, Y., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0359 · Cited by 72
“So far, the http://erc.endocrinology-journals.org q 2016 Society for Endocrinology DOI: 10.1530/ERC-15-0359 Printed in Great Britain function of a few PARPs including PARP1, PARP2, and PARP5 have been well-characterized (Gibson & Kraus 2012).”
InfluentialMartire, S., Fuso, A., Mosca, L., Forte, E., Correani, V., Fontana, M., Scarpa, S., Maras, B., & d’Erme, M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151040 · Cited by 63
MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD+ consumption
Marjanović, M. P., Hurtado-Bagès, S., Lassi, M., Valero, V., Malinverni, R., Delage, H., Navarro, M., Corujo, D., Guberović, I., Douet, J., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3481 · Cited by 64
Melikishvili, M., Chariker, J. H., Rouchka, E. C., & Fondufe‐Mittendorf, Y. N. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.43 · Cited by 65
Carter-O’Connell, I., Vermehren‐Schmaedick, A., Jin, H., Morgan, R. K., David, L. L., & Cohen, M. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00567 · Cited by 64
Resolving DNA Damage: Epigenetic Regulation of DNA Repair
Karakaidos, P., Karagiannis, D., & Rampias, T. N. (2020) · Molecules · doi:10.3390/molecules25112496 · Cited by 68
“PARP1 catalyzes the formation of linear chains of ADP-ribose residues (PAR chains) that form a platform to recruit DNA repair proteins via their PAR-binding domains at the sites of DNA damage [27,28].”
BackgroundBAP1 as a guardian of genome stability: implications in human cancer
Kwon, J., Lee, D., & Lee, S.-A. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00979-1 · Cited by 71
Crosstalk between SET7/9-dependent methylation and ARTD1-mediated ADP-ribosylation of histone H1.4
Kassner, I., Barandun, M. A., Fey, M., Rosenthal, F., & Hottiger, M. O. (2013) · Epigenetics & Chromatin · doi:10.1186/1756-8935-6-1 · Cited by 63
“It is implicated in many cellular processes such as the genotoxic stress response, cell cycle regulation, gene expression, differentiation and aging [18,19].”
Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease
Matasic, D. S., Brenner, C., & London, B. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00409.2017 · Cited by 66
“PARPs have been shown to alter protein-protein and protein-RNA interactions, modulate protein localization, and signal for ubiquitination (31).”
PARP1 and Poly(ADP-ribosyl)ation Signaling during Autophagy in Response to Nutrient Deprivation
Rodríguez-Vargas, J. M., Oliver, F. J., & Dantzer, F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2641712 · Cited by 68
“Since the major source to create secondary metabolites and antioxidant precursors is blocked, this creates a negative feedback loop that compromises cell survival [7, 8].”
BackgroundDDX18 prevents R-loop-induced DNA damage and genome instability via PARP-1
Lin, W.-L., Chen, J.-K., Wen, X., He, W., Zarceno, G. A., Chen, Y., Chen, S., Paull, T. T., & Liu, H. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111089 · Cited by 65
Li, P., Zhen, Y., Kim, C., Liu, Z., Hao, J., Deng, H., Deng, H., Zhou, M., Wang, X., Qin, T., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg7752 · Cited by 66
Chemical methods for the proteome-wide identification of posttranslationally modified proteins
Chuh, K. N., & Pratt, M. R. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.10.020 · Cited by 64
“ADP-ribosylation ADP-ribosylation is the posttranslational addition of ADPribose from a nicotinamide adenine dinucleotide (NAD) donor to a range of different amino acid side-chains [52].”
Microglial activation induced by the alarmin S100B is regulated by poly(ADP‐ribose) polymerase‐1
Xu, J., Wang, H., Won, S. J., Basu, J., Kapfhamer, D., & Swanson, R. A. (2016) · Glia · doi:10.1002/glia.23026 · Cited by 64
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.